Natera - 10 Year Stock Price History | NTRA
Historical daily share price chart and data for Natera since 2015 adjusted for splits and dividends. The latest closing stock price for Natera as of May 23, 2025 is 153.32.
- The all-time high Natera stock closing price was 177.00 on February 05, 2025.
- The Natera 52-week high stock price is 183.00, which is 19.4% above the current share price.
- The Natera 52-week low stock price is 92.14, which is 39.9% below the current share price.
- The average Natera stock price for the last 52 weeks is 138.67.
| Natera Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 156.5144 | 160.6000 | 177.0000 | 132.2300 | 153.3200 | -3.15% |
| 2024 | 109.7520 | 61.9200 | 174.0000 | 59.2100 | 158.3000 | 152.71% |
| 2023 | 49.9957 | 38.4900 | 62.6400 | 36.5700 | 62.6400 | 55.94% |
| 2022 | 46.4666 | 91.3300 | 91.3300 | 28.1300 | 40.1700 | -56.99% |
| 2021 | 107.5655 | 96.3100 | 126.3600 | 86.0500 | 93.3900 | -6.16% |
| 2020 | 53.7034 | 33.2900 | 111.7400 | 17.2700 | 99.5200 | 195.40% |
| 2019 | 26.1781 | 12.9500 | 40.4000 | 11.3400 | 33.6900 | 141.33% |
| 2018 | 16.1340 | 9.4700 | 28.9600 | 8.7900 | 13.9600 | 55.28% |
| 2017 | 10.2984 | 11.8900 | 14.3100 | 7.5000 | 8.9900 | -23.23% |
| 2016 | 10.4886 | 10.3400 | 13.7900 | 6.6100 | 11.7100 | 8.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.821B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.174B | 25.17 |
| Elevance Health (ELV) | United States | $86.874B | 11.21 |
| CVS Health (CVS) | United States | $76.179B | 9.47 |
| Cencora (COR) | United States | $56.230B | 19.56 |
| DiDi Global (DIDIY) | China | $23.297B | 35.36 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.571B | 13.31 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.522B | 0.00 |
| CochLear (CHEOY) | Australia | $11.391B | 0.00 |
| Revvity (RVTY) | United States | $10.665B | 18.35 |
| ICON (ICLR) | Ireland | $10.255B | 9.53 |
| Viatris (VTRS) | United States | $9.976B | 3.43 |
| Doximity (DOCS) | United States | $9.570B | 44.57 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.657B | 42.59 |
| Medpace Holdings (MEDP) | United States | $8.422B | 22.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.660B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.994B | 36.97 |
| Bausch + Lomb (BLCO) | Canada | $3.976B | 23.44 |
| Sotera Health (SHC) | United States | $3.480B | 19.77 |
| Surgery Partners (SGRY) | United States | $2.896B | 37.67 |
| Alignment Healthcare (ALHC) | United States | $2.867B | 0.00 |
| Concentras Parent (CON) | United States | $2.744B | 15.86 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.117B | 9.02 |
| GeneDx Holdings (WGS) | United States | $1.921B | 73.99 |
| Premier (PINC) | United States | $1.910B | 14.50 |
| Progyny (PGNY) | United States | $1.791B | 39.42 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.200B | 9.13 |
| Establishment Labs Holdings (ESTA) | $1.066B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.953B | 14.88 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| Nutex Health (NUTX) | United States | $0.901B | 13.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.614B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| LifeMD (LFMD) | United States | $0.523B | 0.00 |
| Enhabit (EHAB) | United States | $0.520B | 42.75 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 11.37 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| SBC Medicals (SBC) | United States | $0.398B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.388B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.214B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.098B | 0.00 |
| So-Young (SY) | China | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |